Get started
GRI Bio, Inc.GRI Bio, Inc.GRI Bio, Inc.

GRI Bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

GRI chart

Key stats

Market capitalization
‪1.43 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−63.5806USD
Net income
‪−13.04 M‬USD
Revenue
—
Shares float
‪3.00 M‬
Beta (1Y)
−0.49

About GRI Bio, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
W. Marc Hertz
Website
gribio.com
Headquarters
La Jolla
Employees (FY)
4
Founded
2009
FIGI
BBG00XZQMLV6
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GRI is 0.4374 USD — it has decreased by 2.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GRI Bio, Inc. stocks are traded under the ticker GRI.
GRI Bio, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
GRI stock is 9.96% volatile and has beta coefficient of −0.49. Check out the list of the most volatile stocks — is GRI Bio, Inc. there?
GRI earnings for the last quarter are −42.00 USD per share, whereas the estimation was −48.30 USD resulting in a 13.04% surprise. The estimated earnings for the next quarter are −52.50 USD per share. See more details about GRI Bio, Inc. earnings.
Yes, you can track GRI Bio, Inc. financials in yearly and quarterly reports right on TradingView.
GRI stock has fallen by 15.95% compared to the previous week, the month change is a 43.92% fall, over the last year GRI Bio, Inc. has showed a 99.18% decrease.
GRI net income for the last quarter is ‪−2.00 M‬ USD, while the quarter before that showed ‪−2.14 M‬ USD of net income which accounts for 6.22% change. Track more GRI Bio, Inc. financial stats to get the full picture.
Today GRI Bio, Inc. has the market capitalization of ‪1.43 M‬, it has decreased by 12.10% over the last week.
No, GRI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GRI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRI Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GRI reached its all-time high on Sep 10, 2021 with the price of 2175.6000 USD, and its all-time low was 0.5031 USD and was reached on Apr 4, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 4.00 employees. See our rating of the largest employees — is GRI Bio, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRI Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRI Bio, Inc. stock shows the sell signal. See more of GRI Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.